Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. (Q45778660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jessica Zucman-Rossi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

S Oudard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

O Rixe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

P Wolter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Blesius

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

J Ayllon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

R Elaidi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

P Schöffski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

E Barrascout

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Morel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

B Escudier

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

H Lang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

J Medioni

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

11 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

794-800

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Novel approaches in the therapy of metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Treatment options in renal cell carcinoma: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Renal cell carcinoma bone metastases: clinical advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Sorafenib for metastatic renal cancer: the Princess Margaret experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ554

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ554

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference